iRadimed (FRA:46K) Total Operating Expense: €32.95 Mil (TTM As of Mar. 2026)


FRA:46K iRadimed Corp FRA:46K
87 GF Score
Price €84.50
GF Value €56.24
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is iRadimed Total Operating Expense?

iRadimed FRA:46K +1.81% 87 Total Operating Expense is €32.95 Mil as of Mar. 2026. GuruFocus rates FRA:46K with a GF Score™ of 87/100 and a GF Value™ of €56.24 (Significantly Overvalued). The stock has 6 warning signs investors should review.

iRadimed's Total Operating Expense for the three months ended in Mar. 2026 was €8.28 Mil. iRadimed's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was €32.95 Mil.

iRadimed Total Operating Expense Related Terms

iRadimed Total Operating Expense Historical Data

* Premium members only.

The historical data trend for iRadimed's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iRadimed Total Operating Expense Chart

iRadimed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.68 24.22 27.62 32.84 32.60

iRadimed Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.71 7.95 8.23 8.49 8.28
FRA:46K
87GF Score
iRadimed Corp FRA:46K
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

iRadimed Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €32.95 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of €32.95 Mil mean?
iRadimed (FRA:46K) has a Total Operating Expense of €32.95 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on iRadimed and its competitors.
Is iRadimed's Total Operating Expense too high?
iRadimed's current Total Operating Expense is €32.95 Mil. Overall, iRadimed has a GF Score™ of 87/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does iRadimed's Total Operating Expense compare to AVNS and LMRI?
iRadimed's Total Operating Expense of €32.95 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on iRadimed and its competitors. iRadimed's current Total Operating Expense is €32.95 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iRadimed stock overvalued right now?
Based on GuruFocus' analysis, iRadimed (FRA:46K) is currently considered Significantly Overvalued. The stock's GF Value™ is €56.24, compared to a current price of €84.50 — trading 50.2% above its estimated fair value. The current Total Operating Expense is €32.95 Mil. iRadimed's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For iRadimed (FRA:46K), the current Total Operating Expense is €32.95 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is iRadimed (FRA:46K) Overvalued in 2026?

Based on GuruFocus' analysis, iRadimed stock appears to be overvalued. The current stock price of €84.50 is trading 50.2% above its estimated GF Value™ of €56.24. GuruFocus considers iRadimed to be Significantly Overvalued.

Key valuation signals for FRA:46K:

  • Total Operating Expense: €32.95 Mil
  • GF Value™: €56.24 vs. price of €84.50 (50.2% above fair value)
  • GF Score™: 87/100 with 6 warning signs

No single metric tells the full story. See the FRA:46K stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

iRadimed Business Description

Other Exchanges IRMD:USA
Address 12705 Ingenuity Drive, Orlando, FL, USA, 32826
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
87GF Score

Get the complete analysis for FRA:46K

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€84.50
Price
€56.24
GF Value